首页> 中文期刊> 《癌症生物学与医学:英文版》 >Serum CA125, CA199, CEA, CA724, and AFP for diagnosis and prognosis prediction in patients with intrahepatic cholangiocarcinoma

Serum CA125, CA199, CEA, CA724, and AFP for diagnosis and prognosis prediction in patients with intrahepatic cholangiocarcinoma

         

摘要

Objective:Intrahepatic cholangiocarcinoma(ICC)is a malignancy that involves difficulties in early diagnosis and has extremely poor prognosis.This study aimed to evaluate serum carbohydrate antigen 125(CA125),serum carbohydrate antigen 199(CA199),carcinoembryonic antigen(CEA),carbohydrate antigen 724(CA724)and alpha-fetoprotein(AFP)as biomarkers for diagnosis and prognosis of ICC patients.

著录项

  • 来源
    《癌症生物学与医学:英文版》 |2018年第s01期|P.8-9|共2页
  • 作者单位

    Comprehensive Liver Cancer Center The 302 Hospital Beijing China;

    Integrated TCM&Western Medicine Department The 302 Hospital Beijing China;

    Comprehensive Liver Cancer Center The 302 Hospital Beijing China;

    Comprehensive Liver Cancer Center The 302 Hospital Beijing China;

    Comprehensive Liver Cancer Center The 302 Hospital Beijing China;

    Comprehensive Liver Cancer Center The 302 Hospital Beijing China;

    Comprehensive Liver Cancer Center The 302 Hospital Beijing China;

    Comprehensive Liver Cancer Center The 302 Hospital Beijing China;

  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 胆囊、胆道肿瘤;
  • 关键词

    CA125; CA199; CEA;

    机译:CA125;CA199;一个;
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号